<DOC>
	<DOCNO>NCT00326196</DOCNO>
	<brief_summary>This randomize , multi-site , clinical trial compare percutaneous coronary stenting ( PCI ) drug elude stent coronary bypass angiographically significant coronary artery disease diabetes . The hypothesis test strategy surgical revascularization superior percutaneous intervention prevent death myocardial infarction diabetic severe ischemic heart disease .</brief_summary>
	<brief_title>Coronary Artery Revascularization Diabetes</brief_title>
	<detailed_description>Diabetic patient ( HbA1c great 6.0 % treat great 6.9 % untreated ) severe ischemic heart disease clinical indication coronary revascularization screen , agreeable , enter study . Qualified patient unwilling participate randomize trial approach participation Registry collect computerize health data . The study consist 4-year accrual period . The median follow-up 3.7 year maximum six year minimum two year . Six sit begin recruitment first year follow nine additional site remain three year . The study power detect 40 % relative difference group time death MI two-sided , type I error 5 % power 90 % .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patients diabetes severe coronary artery disease General Inclusion Criteria 1 . Age least 18 year old 2 . Patients either Type I Type II diabetes document HbA1c great site ULN ( If diabetic medication must confirm blood glucose &gt; 126 mg/dL fasting , &gt; 200mg/dL nonfasting ) ; OR diabetic medication document physician diagnosis diabetes mellitus . 3 . No child bear potential ( female ) 4 . Patient competent provide consent General Exclusion Criteria 5 . Congenital heart disease 6 . Coronary bypass surgery within precede one year 7 . Need concomitant cardiac surgery 8 . AHA Class III decompensated heart failure AHA Class IV heart failure 9 . Undergoing PCI hemodynamic instability relate acute STEMI 10 . History hemorrhagic stroke 11 . Severe bleed diathesis 12 . History chronic pancreatitis 13 . A severe comorbid condition expect limit life less two year 14 . Embolic stroke past six month 15 . Significant GI bleed within last one month 16 . Lack adequate surgical conduit 17 . Sensitivity clopidogrel ( Plavix ) 18 . Sensitivity glycoprotein IIb/IIIa inhibitor 19 . Chronic systemic steroid use 20 . Participation another trial active intervention 21 . Patient unable adequately follow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>CABG</keyword>
	<keyword>Coronary Disease</keyword>
	<keyword>Diabetes</keyword>
	<keyword>PCI</keyword>
</DOC>